drugset
Drugs / HeV-sG-V
last change May 2022 re-read 3 minutes ago

HeV-sG-V

also known as Nipah Vaccine, HenipaVaxTM

Vaccine

Developed for
Nipah virus disease
Investigated by
Auro Vaccines LLC · Children's Hospital Medical Center, Cincinnati · Coalition for Epidemic Preparedness Innovations · PATH

Trials 1

today NCT04199169 · Ph 1
2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04199169 Feb 2020 → May 2022 Nipah virus disease Auro Vaccines LLC Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as HeV-sG-V ClinicalTrials.gov intervention name — accepted as the source's own label NCT04199169 ↗
Known as Nipah Vaccine, HenipaVaxTM “Nipah Vaccine, HenipaVaxTM” NCT04199169 ↗
Modality Vaccine “Nipah vaccine” NCT04199169 ↗